Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
About Injections
Vial liquids, ampoules, and dry powder injections are the three container closure systems used by 9M India’s WHO-GMP-certified sterile manufacturing facility for manufacturing small-volume parenterals.

Our portfolio of injectables covers five key therapeutic areas: analgesic and pain relief, anaesthetic, cardiovascular, gastrointestinal, and anti-inflammatory formulations. All molecules in our portfolio have valid DCGI manufacturing licences and complete regulatory paperwork.
Manufacturing is undertaken in classified cleanroom environments in validated aseptic processes. Each batch is only released after full in-house testing. This includes sterility, particles, endotoxin levels and potency testing. Every batch is accompanied by a Certificate of Analysis from our own QC laboratory.
For buyers requiring institutional tender supply, export registration or third-party contract manufacturing, our documentation package (COA, COC, stability data and regulatory dossiers) is pre-prepared and available within 24 hours of request.
A team of 700+ professionals supports 9M India, which is trusted by 200+ clients worldwide. We run with strong compliance and regulatory systems, supported by comprehensive documentation that is aligned with domestic and international quality standards, ensuring consistent, reliable and audit-ready manufacturing.
Our Capabilities
Our sterile injectable facility is designed to manage every aspect of parenteral manufacturing, including formulation development, aseptic fill-finish, regulatory release, and cold chain dispatch.
01
Our injectable manufacturing is carried out in classified cleanroom environments for aseptic manufacturing. The ampoule sealing, dry powder filling and vial liquid fill-finish operations are performed under validated conditions with standard contamination controls, personnel gowning practices and environmental monitoring. Documented process parameters are reviewed and maintained for regulatory inspection.
02
9M India manufactures Small Volume Parenterals in all three major container types. Liquid vials for single and multi-dose requirements. Ampoules for sterile single-dose preparations. Dry powder injections require reconstitution at point of use. As part of our standard quality release protocol, we test all batches for container closure integrity.
03
We test all injectable batches in our in-house analytical laboratory before dispatch. The tests include sterility, particulate matter (visible and sub-visible), bacterial endotoxins (LAL test), pH, assay and related substances. Certificates of Analysis are issued from our own QC facility, not a third-party laboratory, ensuring complete chain-of-custody accountability of each batch released.
04
Our documentation is prepared to meet all institutional, export and tender requirements. We can provide you with the manufacturing licence, DCGI product approvals, WHO-GMP certificates, certificates of analysis and conformance, stability study data (as per ICH), process validation reports and product dossiers for export registration upon request. We support institutional and governmental tender submissions with standard technical bids.
05
Storage and distribution of injectable formulations require specific temperatures. Our facility supports ambient (+15° to +30°C), controlled room temperature (+15° to +25°C) and refrigerated (+2° to +8°C) storage. From our facility to the final delivery location, we oversee cold chain logistics and keep temperature records that are accessible for regulatory inspection.
Therapeutic Categories
Our injectable portfolio covers the five therapeutic categories most frequently demanded in institutional supply, hospital procurement and international export programmes.
Analgesic (Pain-Relief) Injections
High-purity non-opioid analgesic injectables — the most widely procured injectable category in government and institutional hospital supply.
Anaesthetic Injections
Sterile anaesthetic injectables for surgical, procedural, and regional anaesthesia — manufactured to meet strict purity and stability standards.
Cardiovascular Injections
Critical care cardiovascular injectables — including antihypertensives, antiarrhythmics, and anticoagulants for ICU and emergency use.
Gastrointestinal (GI) Injections
GI injectable formulations for hospital and critical care — covering anti-emetics, corticosteroids, and PPIs in multiple formats.
Anti-inflammatory Injections
Anti-inflammatory injectable solutions including corticosteroids and NSAIDs — commonly used in orthopaedic and post-surgical care.
Why Choose Us
The most complex area of pharmaceutical manufacturing is sterile injectable manufacturing. It requires classified infrastructure, validated processes and discipline in documentation that most manufacturers are unable to do at scale. 9M India is just perfect for this purpose.
Each batch is manufactured to the sterile manufacturing standard with validated sterilisation, aseptic fill-finish, classified cleanroom environments and in-process environmental monitoring.
9M India is now among the few Indian manufacturers with WHO-GMP certification for sterile injectable manufacturing. This certification allows us to supply to international institutions, participate in government tenders and export to regulated markets in over 15 countries.
COA, COC, sterility test reports, endotoxin data, stability dossiers, DCGI approvals, and WHO-GMP certificates are archived, version controlled, and ready for submission within 24 hrs. Our paperwork will not affect your tender deadline.
Our Injections Range
Key molecules from our portfolio of injectable manufacturing solutions ranging all five therapeutic categories, three container formats and the full scope of institutional and export supply requirements
Paracetamol
Analgesic · Pain-Relief Container: Vial liquid Type: Non-opioid analgesic
Propofol
Anaesthetic Container: Vial liquid Type: General anaesthesia
Lidocaine
Anaesthetic Container: Ampoule Type: Local anaesthesia
Ropivacaine
Anaesthetic Container: Ampoule Type: Regional anaesthesia
Heparin
Cardiovascular Container: Vial liquid Type: Anticoagulant
Labetalol
Cardiovascular Container: Ampoule Type: Antihypertensive
Adenosine
Cardiovascular Container: Vial liquid Type: Antiarrhythmic
Ondansetron
Gastrointestinal Container: Vial liquid Type: Anti-emetic
Pantoprazole
Gastrointestinal Container: Dry powder Type: Proton Pump Inhibitor
Methylprednisolone
Gastrointestinal Container: Dry powder Type: Corticosteroid
Dexamethasone
Anti-inflammatory Container: Ampoule Type: Corticosteroid
Ketorolac
Anti-inflammatory Container: Ampoule Type: NSAID
We keep answer short
01
9M India produces Small Volume Parenterals (SVP) in three container closure systems – vial liquids, ampoules and dry powder injections. Our range of injectable products include five therapeutic areas: analgesic and pain-relief, anaesthetic, cardiovascular, gastrointestinal and anti-inflammatory products. Key molecules include Paracetamol, Propofol, Lidocaine, Heparin, Ondansetron, Pantoprazole, Dexamethasone and Ketorolac to name a few.
02
Yes, our manufacturing facility is WHO-GMP compliant and has a classified cleanroom environment for the manufacture of sterile injectables. Environmental monitoring is routine, and aseptic fill-finish processes are validated. The facility
03
The three main injectable formats that we produce are glass ampoules, dry powder injections for molecules that need to be reconstituted at the point of use, and vial liquids (both single and multi-dose). As a standard release protocol, every batch undergoes container closure integrity testing.
04
Yes, 9M India has experience supplying injectables to government and institutional clients , including central procurement, CGHS and ESIC supply, and state tender programmes. Our injectable products are DCGI-approved, and our documentation package, which includes the COA, COC, stability data, manufacturing licence, and WHO-GMP certificate, prepared for tender bid submission without any lead time.
05
We supply standard documentation with every batch, including a Certificate of Analysis (COA) and a Certificate of Conformance (COC) from our QC laboratory. We also provide for export registration and regulatory filing: stability study data (as per ICH conditions), process validation reports, product dossiers, DCGI manufacturing licenses, and WHO-GMP certificates. Documentation will be provided within 24 hours of request.
Share your requirement - product availability, documentation and lead times confirmed within 24 hours.